In the last trading session, 151.3 million shares of the Rallybio Corp (NASDAQ:RLYB) were traded, and its beta was -1.17. Most recently the company’s share price was $0.51, and it changed around $0.17 or 50.24% from the last close, which brings the market valuation of the company to $21.29M. RLYB currently trades at a discount to its 52-week high of $1.54, offering almost -201.96% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has risen by an impressive 56.86% since then. We note from Rallybio Corp’s average daily trading volume that its 10-day average is 15.28 million shares, with the 3-month average coming to 200.92K.
Rallybio Corp stock received a consensus recommendation rating of Hold, based on a mean score of 2.50. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 3 recommended RLYB as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Rallybio Corp (NASDAQ:RLYB) trade information
Instantly RLYB has showed a green trend with a performance of 50.24% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.6049 on recent trading dayincreased the stock’s daily price by 15.69%. The company’s shares are currently down -60.05% year-to-date, but still up 51.30% over the last five days. On the other hand, Rallybio Corp (NASDAQ:RLYB) is 50.77% up in the 30-day period. We can see from the shorts that 0.33 million shares have been sold at a short interest cover period of 1.3 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -19.41%.
RLYB Dividends
Rallybio Corp’s next quarterly earnings report is expected to be released on 2025-May-08.
Rallybio Corp (NASDAQ:RLYB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.16% of Rallybio Corp shares, and 76.90% of them are in the hands of institutional investors. The stock currently has a share float of 80.24%. Rallybio Corp stock is held by 48.0 institutions, with VIKING GLOBAL INVESTORS LP being the largest institutional investor. By 2024-06-30, it held 10.288% of the shares, which is about 4.19 million shares worth $5.62 million.
JOHNSON & JOHNSON, with 8.9184% or 3.64 million shares worth $4.87 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
abrdn Healthcare Investors and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 755.08 shares worth $0.39 million, making up 1.81% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 649.66 shares worth around $0.33 million, which represents about 1.56% of the total shares outstanding.
